Protein Tyrosine Phosphatase, Receptor Type B (PTPRB) Inhibits Brown Adipocyte Differentiation through Regulation of VEGFR2 Phosphorylation

Abstract

Brown adipocytes have an important role in the regulation of energy balance through uncoupling protein‐1 (UCP‐1)‐mediated nonshivering thermogenesis. Although brown adipocytes have been highlighted as a new therapeutic target for the treatment of metabolic diseases, such as obesity and type 2 diabetes in adult humans, the molecular mechanism underlying brown adipogenesis is not fully understood. We recently found that protein tyrosine phosphatase receptor type B (PTPRB) expression dramatically decreased during brown adipogenic differentiation. In this study, we investigated the functional roles of PTPRB and its regulatory mechanism during brown adipocyte differentiation. Ectopic expression of PTPRB led to a reduced brown adipocyte differentiation by suppressing the tyrosine phosphorylation of VEGFR2, whereas a catalytic inactive PTPRB mutant showed no effects on differentiation and phosphorylation. Consistently, the expression of brown adipocyte‐related genes, such as UCP‐1, PGC‐1α, PRDM16, PPAR‐γ and CIDEA, were significantly inhibited by PTPRB overexpression. Overall, these results suggest that PTPRB functions as a negative regulator of brown adipocyte differentiation through its phosphatase activity‐dependent mechanism and may be used as a target protein for the regulation of obesity and diabetes. Support or Funding Information This work was supported by grants from the KRIBB and from the Research Program (grants 2016R1C1B2013430, 2015M3A9B5030308, 2015M3A7B6027948, and 2015M3A9D7029882) through the National Research Foundation of Korea. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Crucial lncRNAs associated with adipocyte differentiation from human adipose-derived stem cells based on co-expression and ceRNA network analyses

“…The study of Kim et al showed ectopic over-expression of PTPRB inhibited the expression of adipocyte-related genes (such as PPAR-γ) and led to a reduced adipocyte differentiation from preadipocytes. Also, PTPRB was reported to suppress the tyrosine phosphorylation of VEGFR2 during adipocyte differentiation (Kim et al, 2019). Generally, VEGF functions by binding with VEGFR2, while transfection of VEGF to ASCs increased fat cell survival (Zhang et al, 2017).…”

A Comparative Analysis of the Wound Healing-Related Heterogeneity of Adipose-Derived Stem Cells Donors

“…PTPRB, a member of the protein tyrosine phosphatase (PTP) family, is an enzyme mainly expressed in endothelial cells essential for blood vessel remodeling and angiogenesis [ 49 ]. In ASCs, it has been linked to reduced adipocyte differentiation [ 52 ]. Moreover, the transcripts T-box transcription factor 1 (TBX1) and endothelial PAS domain-containing protein 1 (EPAS1) were identified, both giving rise to transcription factors.…”

Long non-coding RNAs in regulation of adipogenesis and adipose tissue function

“…LINC01119 might positively influence the transcription of protein tyrosine phosphatase receptor type B (PTPRB), which is involved in pathways that counteract adipose differentiation. In fact, PTPRB acts as a negative regulator of brown adipogenesis by suppressing the tyrosine phosphorylation of VEGFR2, and its expression decreases during BAT formation ( Kim et al, 2019 ). By interacting with its cognate ligand (VEGF), the VEGFR2 receptor has a major role in brown adipose tissue development and maintenance ( Bagchi et al, 2013 ).…”